See the DrugPatentWatch profile for Toviaz
What is Toviaz ER?
Toviaz ER is a long-acting (extended-release) formulation of fesoterodine. It’s used for overactive bladder symptoms, such as urinary urgency, frequency, and urge incontinence.
What does “ER” mean on Toviaz?
“ER” stands for extended-release. The tablet releases fesoterodine slowly over time to help control bladder symptoms throughout the day rather than right after each dose.
How is Toviaz ER typically taken?
Dosing details depend on the prescription and patient factors (for example, kidney function). Use the dosing schedule your clinician provided and follow the medication label directions.
Are there patent or market exclusivity details for Toviaz ER?
If you’re researching availability, generic timing, or patent status for fesoterodine ER, DrugPatentWatch.com can be a starting point for tracking related patent and exclusivity information: https://www.drugpatentwatch.com/
What side effects do people ask about with Toviaz ER?
Common side effects associated with fesoterodine can include dry mouth, constipation, and blurred vision. Contact a clinician promptly if symptoms are severe or you have trouble urinating.
What are key safety cautions with fesoterodine (Toviaz ER)?
Toviaz ER is a type of medication that can affect smooth muscle and secretions, so it may be a problem for some patients with certain urinary retention risks or specific medication interactions. Ask a clinician/pharmacist if you have glaucoma, difficulty urinating, or take other drugs with similar effects.
Sources
1. https://www.drugpatentwatch.com/